Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft - Landuzzi, Lorena; Palladini, Arianna; Ceccarelli, Claudio; Asioli, Sofia; Nicoletti, Giordano; Giusti, Veronica; Ruzzi, Francesca; Ianzano, Marianna L.; Scalambra, Laura; Laranga, Roberta; Balboni, Tania; Arigoni, Maddalena; et al. (Scientific reports, 2021)
Keywords: 631/67/1059; 631/67/1347; 631/67/2329; 631/67/70; 631/67/71; Breast cancer; Enzyme inhibitors; ErbB-2 protein; Gene expression; Growth rate; Humanities and Social Sciences; Immunodeficiency; Kinases; Mesenchyme; Metastases; Monoclonal antibodies; multidisciplinary; Phenotypes; Protein-tyrosine kinase; Science; Science (multidisciplinary); Senescence; Stem cells; Targeted cancer therapy; Trastuzumab; Xenografts